This site is intended for healthcare professionals
News

Verzenio significantly reduced the risk of cancer returning in people with high risk HR+, HER2- early breast cancer.- Eli Lilly

Read time: 2 mins
Last updated:17th Jun 2020
Published:17th Jun 2020
Condition: Breast Cancer HER2-
Type: drug
Register free for full access to medthority.com